Today's Stocks Driving Success For The Health Services Industry

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 161 points (1.1%) at 14,992 as of Friday, May 3, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 2,292 issues advancing vs. 653 declining with 100 unchanged.

The Health Services industry currently sits up 0.9% versus the S&P 500, which is up 1.2%. Top gainers within the industry include Mettler-Toledo International ( MTD), up 8.0%, Tenet Healthcare ( THC), up 2.7%, Varian Medical Systems ( VAR), up 2.3%, CareFusion ( CFN), up 2.2% and Boston Scientific ( BSX), up 1.5%. On the negative front, top decliners within the industry include Select Medical Holdings Corporation ( SEM), down 7.13, Edwards Life ( EW), down 1.09 and Humana ( HUM), down 1.12.

TheStreet Ratings group would like to highlight 5 stocks pushing the industry higher today:

5. Agilent Technologies ( A) is one of the companies pushing the Health Services industry higher today. As of noon trading, Agilent Technologies is up $0.44 (1.07) to $41.92 on average volume Thus far, 2.2 million shares of Agilent Technologies exchanged hands as compared to its average daily volume of 3.7 million shares. The stock has ranged in price between $41.90-$42.55 after having opened the day at $41.93 as compared to the previous trading day's close of $41.48.

Agilent Technologies, Inc. provides bio-analytical and electronic measurement solutions and services to the life sciences, chemical analysis, diagnostics and genomics, communications, and electronics industries worldwide. Agilent Technologies has a market cap of $14.3 billion and is part of the health care sector. The company has a P/E ratio of 13.2, below the S&P 500 P/E ratio of 17.7. Shares are up 0.9% year to date as of the close of trading on Thursday. Currently there are 14 analysts that rate Agilent Technologies a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates Agilent Technologies as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Agilent Technologies Ratings Report now.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.

If you liked this article you might like

What a Difference a Day Makes for New SEC Rule

Jim Cramer: Agilent Technology Has Been One of My Favorites

Jim Cramer -- Agilent Is 'Continuing to Defy Gravity'

Biotech Movers: Disappointment for Bristol-Myers Kidney Combo Boosts Exelixis